普通麻将千术教程:Overseas Pharmaceuticals is Invited to Participate in the US Biotechnology Exhibition
|Time：2017-06-23 17:22:17 Form： Writer：|
贵阳雀友麻将机维修 www.bcmfs.tw 2017 BIO International Convention was held at the San Diego Convention Center in San Diego (USA) from 19 to 22 June, 2017. Dr. Fan Jun, VP of R&D and Dr. Cai Huaihan, Assistant Manager / New Drug R&D Manager were invited to attend the convention. They carried products, patent certificates and approval documents as well as company brochures and souvenirs to the exhibition. The goal of Overseas Pharmaceuticals is very clear. On the one hand is to know more about the current developing situation of small and medium-sized pharmaceutical enterprises and their drug research. On the other hand is to seek the US FDA and the EU EMA drug registration experts, clinical experts as well as international patent registration agents. But the most important thing is to discuss possible technology and product corporations with multinational enterprises (GSK Pfizer etc.).
During the exhibition, Dr. Fan and Dr. Cai were also invited to participate in the former meeting of Business Investment Convention which was held by Belgian government. At the meeting, Dr. Fan and Dr. Cai learnt relevant registration and taxation policies of R&D high-tech enterprises in Belgium which is located in the center of the EU. Also they learnt the research progress of some small and medium-sized pharmaceutical companies in Belgium including cancer treatment with CART cell from Celyad, development of new-generation cancer vaccine from PDCline, cooperative development of two kinds of new compound and screening of new targets against cancer from Pfizer and iTeos. One part of the exhibition is to make one-to-one negotiations with domestic and foreign enterprises. Dr. Fan was responsible for the appointments with 30 companies so that his schedule is almost full. During the entire exhibition, a total number of 100 brochures, 200 commemorative pencils and 50 ball-pens were given out. In addition two doctors received about 100 business cards of all concerned including government agencies, domestic and foreign pharmaceutical companies (mainly from Europe and the United States), service companies.
Much has been gained in the United States Biotechnology Exhibition:
1) Negotiating with a responsible person who is in charge of business investment, finding a docking man for OPL to make overall arrangements in Europe in the future.
2) Meeting Several large pharmaceutical companies engaged in product sales and purchase.
3) Encountering several enterprises which focus on FDA registration, patent commissioning and clinical CRO.
4) Encountering several agencies which provide reference preparation purchasing service.
5) Meeting several pharmaceutical companies which are engaged in characteristic platform technology.
Finally OPL would like to thank the work and help of China International Chamber and Jiangsu Huichang Exhibition Center.